Literature DB >> 18536267

Blockers of monoamine transporters influence high dopamine concentration uptake in rat brain slices.

M Yu Iniouchine1, D A Sibarov, A B Volnova, C A Jimenez-Rivera, A D Nozdrachev.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18536267     DOI： 10.1134/s0012496608020038

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN： 0012-4966


× No keyword cloud information.
  14 in total

Review 1.  Psychostimulants and monoamine transporters: upsetting the balance.

Authors:  J Martin Elliott; Thomas J R Beveridge
Journal:  Curr Opin Pharmacol       Date:  2005-02       Impact factor: 5.547

2.  Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition.

Authors:  H K Wayment; J O Schenk; B A Sorg
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

Review 3.  Parkinson's disease and levodopa. A five-year follow-up and review.

Authors:  C H Markham; L J Treciokas; S G Diamond
Journal:  West J Med       Date:  1974-09

4.  Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1.

Authors:  P Arndt; C Volk; V Gorboulev; T Budiman; C Popp; I Ulzheimer-Teuber; A Akhoundova; S Koppatz; E Bamberg; G Nagel; H Koepsell
Journal:  Am J Physiol Renal Physiol       Date:  2001-09

5.  Identification and characterization of a novel monoamine transporter in the human brain.

Authors:  Karen Engel; Mingyan Zhou; Joanne Wang
Journal:  J Biol Chem       Date:  2004-09-23       Impact factor: 5.157

Review 6.  Detecting subsecond dopamine release with fast-scan cyclic voltammetry in vivo.

Authors:  Donita L Robinson; B Jill Venton; Michael L A V Heien; R Mark Wightman
Journal:  Clin Chem       Date:  2003-10       Impact factor: 8.327

Review 7.  The rationale for the use of dopamine agonists in Parkinson's disease.

Authors:  P Jenner
Journal:  Neurology       Date:  1995-03       Impact factor: 9.910

8.  Effects of various dopamine uptake inhibitors on striatal extracellular dopamine levels and behaviours in rats.

Authors:  N Nakachi; Y Kiuchi; M Inagaki; M Inazu; Y Yamazaki; K Oguchi
Journal:  Eur J Pharmacol       Date:  1995-08-04       Impact factor: 4.432

Review 9.  Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

Authors:  Mark J Millan
Journal:  Pharmacol Ther       Date:  2006-03-07       Impact factor: 12.310

10.  Transport of monoamine transmitters by the organic cation transporter type 2, OCT2.

Authors:  D Gründemann; S Köster; N Kiefer; T Breidert; M Engelhardt; F Spitzenberger; N Obermüller; E Schömig
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157
View more
  4 in total

1.  Uptake of pramipexole by human organic cation transporters.

Authors:  Lei Diao; Yan Shu; James E Polli
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

2.  Quinine enhances the behavioral stimulant effect of cocaine in mice.

Authors:  Adriana Huertas; William D Wessinger; Yuri V Kucheryavykh; Priscila Sanabria; Misty J Eaton; Serguei N Skatchkov; Legier V Rojas; Gerónimo Maldonado-Martínez; Mikhail Y Inyushin
Journal:  Pharmacol Biochem Behav       Date:  2014-12-05       Impact factor: 3.533

3.  Implantable Microprobe with Arrayed Microsensors for Combined Amperometric Monitoring of the Neurotransmitters, Glutamate and Dopamine.

Authors:  Tina T-C Tseng; Harold G Monbouquette
Journal:  J Electroanal Chem (Lausanne)       Date:  2012-07-25       Impact factor: 4.464

4.  A Micro-Platinum Wire Biosensor for Fast and Selective Detection of Alanine Aminotransferase.

Authors:  Tran Nguyen Thanh Thuy; Tina T-C Tseng
Journal:  Sensors (Basel)       Date:  2016-05-26       Impact factor: 3.576
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.